Reported May 27, 2020 · Terminated
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional…
Mylan Institutional LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Institutional LLC · 4901 Hiawatha Dr · Rockford, IL · 61103-1287
Is this the product you have?
- Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only
- Manufactured forMylan Institutional LLC, Rockford, IL 61103 USA
- NDC67457-187-50
- Lot codes and dates
Lot #: Lot N1700771EXP October 2020Lot N1800127EXP February 2021
- Amount recalled
- 3,010 vials
Where it was sold
- Nationwide
Why it was recalled
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Institutional LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.